• DPMC Moderators: thegreenhand | tryptakid
  • Drug Policy & Media Coverage Welcome Guest
    View threads about
    Posting Rules Bluelight Rules
    Drug Busts Megathread Video Megathread

News Common antidepressant slashes risk of COVID death, study says

thegreenhand

Administrator
Staff member
Joined
Aug 16, 2019
Messages
4,688

Common antidepressant slashes risk of COVID death, study says​

Saima May Sidik
Nature
29 Oct 2021

A cheap, widely available drug used to treat mental illness cuts both the risk of death from COVID-19 and the need for people with the disease to receive intensive medical care, according to clinical-trial results1.

The drug, called fluvoxamine, is taken for conditions including depression and obsessive–compulsive disorder. But it is also known to dampen immune responses and temper tissue damage, and researchers credit these properties with its success in the recent trial. Among study participants who took the drug as directed and did so in the early stages of the disease, COVID-19-related deaths fell by roughly 90% and the need for intensive COVID-19-related medical care fell by roughly 65%.

Read the full story here.
 
Normally Covid drugs wouldn’t be here in DitM but this one in particular is a psychoactive drug with some sort of additional mechanism to dampen immune response.
 
Top